Connection

Brian Hess to Lymphoma, Non-Hodgkin

Back to Details
This is a "connection" page, showing publications Brian Hess has written about Lymphoma, Non-Hodgkin.
Brian Hess
Connection Strength
0.178
Lymphoma, Non-Hodgkin
  1. Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma. Clin Cancer Res. 2021 06 15; 27(12):3339-3350.
    View in: PubMed
    Score: 0.178
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.